CoChat

Frequency and Characteristics of MODY 1 (HNF4A Mutation) and MODY 5 (HNF1B Mutation): Analysis From the DPV Database

Open access
Warncke, Katharina, Kummer, Sebastian, Raile, Klemens, Grulich-Henn, Jürgen, Woelfle, Joachim, Steichen, Elisabeth, Prinz, Nicole, Holl, Reinhard W · 2019 · The Journal of Clinical Endocrinology & Metabolism

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Abstract

Objective: To characterize the initial presentation and clinical course of patients with hepatocyte nuclear factor (HNF) 4A‒ and HNF1B‒MODY in a multinational registry. Design, Setting, and Participants: Within the Diabetes Patienten Verlaufsdokumentation (DPV) registry, 44 patients with HNF4A- and 35 patients with HNF1B-MODY were characterized and compared with patients <20 years old with type 1 diabetes (T1D)/type 2 diabetes (T2D). Main Outcome Measure: Clinical and laboratory parameters, therapy, metabolic control, and extrapancreatic symptoms in patients with HNF1B-MODY. Results: Patients with both MODY types were significantly older than patients with T1D at diagnosis (HNF4A, 13.8 years, and HNF1B, 13.5 years, vs T1D, 8.8 years; P < 0.0001). Mean C-peptide at diagnosis was higher for HNF4A-MODY than for T1D (1.8 vs 0.9 ng/mL; P < 0.01); 36.4% of patients with HNF4A-MODY and 65.7% of patients with HNF1B-MODY were treated with insulin, whereas 20.5% and 8.6% received oral antidiabetics only (P < 0.05 and P < 0.01 vs T2D). At the most recent visit, glycated hemoglobin levels were lower in HNF4A- and HNF1B-MODY (mean, 6.5% and 6.1%) than in T1D (7.9%; P < 0.0001). In 40% of patients with HNF1B-MODY, extrapancreatic symptoms were reported. Several clinical predictors previously described to differentiate between MODY and T1D or T2D were revalidated by logistic regression analyses in this cohort. Conclusion: The DPV registry enabled us to precisely characterize phenotype and treatment in these two rare MODY types. Although phenotype of HNF4A- and HNF1B-MODY showed distinct differences from those of T1D and T2D, 38% of patients were initially misclassified as having T1D or T2D.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2018-01696

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 41 references

Research works printed but not linked: 2

  1. Glaser, 2003, GeneReviews®. Seattle (WA), 1993
  2. Schlebusch, 2008, POCT 2008. Patientennahe Labordiagnostik, 55

Cited by

See all 53

Metadata

Authors
Warncke, K., Kummer, S., Raile, K., Grulich-Henn, J., Woelfle, J., Steichen, E., Prinz, N., & Holl, R. W.
Affiliations
  • TUM Klinikum (DE)
  • Düsseldorf University Hospital (DE)
  • Stiftung Charité (DE)
  • Department of Pediatrics, University of Heidelberg, Heidelberg, Germany
  • University of Bonn (DE)
  • Innsbruck Medical University (AT)
  • Universität Ulm (DE)
Corresponding author
Warncke, Katharina
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2018-12-10
Volume
104
Issue
3
Pages
845-855
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2905492527
Cited by
52
References
41
Citations by year
2026: 1 · 2025: 11 · 2024: 6 · 2023: 8 · 2022: 10 · 2021: 5 · 2020: 9 · 2019: 2
FWCI
2.45
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
  • OPen Access Repositorium der Universität Ulm (OPARU) (Ulm University) (submittedVersion)
  • mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
  • Universität Ulm, Kommunikations- und Informationszentrum (kiz)
Funders
  • Federal Ministry of Education and Research within the German Center for Diabetes Research (82DZD0017G)
  • INNODIA, supported by the European Union’s Horizon 2020 research and innovation program and “EFPIA”, ‘JDRF” and “The Leona M. and Harry B. Helmsley Charitable Trust (115797)
  • Deutsche Diabetes Gesellschaft
  • Robert Koch Institut
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
HNF4A mutations, HNF1B mutations, hepatocyte nuclear factor, monogenic diabetes, HbA1c, insulin therapy, C-peptide, DPV registry, clinical phenotype
MeSH terms
Adolescent, Age Factors, Child, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diagnosis, Differential, Female, Humans, Hypoglycemic Agents, Insulin, Male, Prospective Studies, Registries, Rare Diseases, Hepatocyte Nuclear Factor 1-beta, Hepatocyte Nuclear Factor 4

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Frequency and Characteristics of MODY 1 (HNF4A Mutation) and MODY 5 (HNF1B Mutation): Analysis From the DPV Database. https://app.cochat.ai/papers/10.1210/jc.2018-01696
The paper
Warncke, K., Kummer, S., Raile, K., Grulich-Henn, J., Woelfle, J., Steichen, E., Prinz, N., & Holl, R. W. (2019). Frequency and Characteristics of MODY 1 (HNF4A Mutation) and MODY 5 (HNF1B Mutation): Analysis From the DPV Database. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2018-01696

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.